Stem Cell Treatment for Degenerative Disc Disease (DDD) and Chronic Back Pain
Degenerative disc disease (DDD) is one of the most common sources of back pain and affects approximately 30 million people every year. It can lead to a chronic debilitating condition and can have a serious negative impact on a person's quality of life. Although several structures within the spine have been identified as sources of pain, the inter-vertebral disc accounts for approx. 40-50% of all chronic lower back pain. When pain from DDD is severe, traditional non-operative treatment may be ineffective.
Research has reported that the injection of bone marrow stem cells into degenerating discs may help slow, and in some cases partially reverse, aspects of their degeneration. This is of interest because slowing disc degeneration may in turn reduce the cascade of secondary problems resulting from degenerating discs, such as chronic back pain, restricted motion, spinal cord and nerve root compression with radiating pain in arms and legs, deformation and inflammation in vertebral bodies (osteochondrosis), facet joint arthrosis and others.
Anatomy of the Inter-Vertebral Disc
Intervertebral discs are the connecting elements between vertebral bodies, and together compose the spine. They are composed of a gelatinous core, the nucleus pulposus, and a fibrous outer ring, the annulus fibrosus. The nucleus pulposus binds water though its healthy proteoglycan matrix.
Degenerative changes cause the proteoglycan matrix to degenerate, resulting in a loss of water of the nucleus pulposus, reducing its ability to act as a shock absorber between adjacent vertebral bodies. It also leads to a loss in height of the intervertebral disc, with consecutive changes such as narrowing of the neuro-foramina, through which the spinal nerve roots exit, putting them at risk of compression, with resulting sciatic pains and loss of muscle strength in the arms and/or legs. Structural derangement of the bones making up the spinal column also result from disc degeneration, leading to secondary arthrosis, loss of mobility and chronic pain.
Diagnosis of the Disc Degeneration
Typical radiographic findings of DDD include disc space narrowing, displacement of vertebral bodies, fusion of adjacent vertebral bodies, and development of bone spurs (osteophytes) originating from the affected vertebral bodies. MRI affords a grading of the degenerative process: the Pfirrmann scale. It ranges from a grade I, healthy, which shows a homogeneously white disc of normal height to a grade V, which shows an almost completely collapsed black and dehydrated disc.
In order to correctly assess secondary changes, high-resolution MRI with para-sagittal depiction of the neuro-foramina in the cervical spine and 3D-sequences after the injection of intravenous contrast agent to depict inflammatory changes is important, but not routinely performed.
At ANOVA, we have developed specific imaging protocols for degenerative disc and spine conditions to obtain the information needed to advise patients on suitable treatment options and the results that may realistically be expected.
Chronic Back Pain Resulting From Degenerative Disc Disease
Degeneration of the inter-vertebral disc can lead to cracks and tears in the annulus fibrosus. With enough pressure on the disc, parts of the nucleus pulposus can seep out through these tears and can cause result in a herniated disc. The disc prolapse, as it is also known, can result in compression of the spinal cord and/or nerve roots exiting from the spinal canal, with pain and functional deficits in arms and legs. With loss of height disc degeneration can also result in narrowing of the neuroforamina and the spinal canal, adding to the impingement of the spinal cord and nerves.
Limitations of Standard Therapies for Degenerative Disc Disease
Established conservative therapies are primarily aimed at controlling symptoms rather than at the underlying disc degeneration. Methods such as physiotherapy, core muscle strengthening and stretching, pain killers and anti-inflammatory medication as well as mesotherapy with injections into the back muscles are used with varying success to control pain and improve the bio-mechanics of the back.
In many cases surgery is the only resort if conservative treatment options do not provide relief within two to three months. Immediate surgery might be mandatory if there is weakness or numbness in the legs, a sign of often irreversible nerve damage.
Surgical approaches for herniated discs resulting from DDD include discectomy, the surgical removal of either parts or the whole damaged inter-vertebral disc. DDD related inflammatory changes in the adjacent vertebral bodies – a condition called active osteochondrosis – often requires spinal fusion with complete removal of the intervertebral disc and stabilization of the affected spinal segment. Spinal fusion, however, permanently impairs the bio-mechanics of the spine and leads to secondary degenerative changes in the adjacent segments.
Bone Marrow Stem Cells in Disc Degeneration
Preclinical research and a number of early clinical trials have reported that the injection of stem cells into degenerating discs may slow, and in some cases temporarily halt, the degeneration of the proteoglycan matrix of the nucleus pulposus and the resulting secondary changes of the spine. A 2012 review from Cedars-Sinai Medical Center (Los Angeles, USA) summarised the findings reported at that time, including observations of improved disc morphology and function following the injection of BMC into degenerating discs.
In a small 2017 clinical trial, the injection of 2 ml of BMC into the nucleus pulposus of degenerating discs was followed by notable clinical improvement: of the 26 treated patients, six had undergone surgery within 36 months. These are early findings from a small patient group.
In the same study, pain scores measured on the VAS (Visual Analogue Scale) fell from 82.1 ± 2.6 before treatment to 21.9 ± 4.4 at 36 months after treatment. Individual outcomes may vary.
MRI scans performed one year after treatment in this study showed that 40% of patients had improved by one Pfirrmann grade, with no patient worsening radiographically.
In this study, no adverse events related to marrow aspiration or injection were reported, supporting the feasibility and tolerability of the procedure in this setting. These results suggest that intradiscal BMC injection may offer a minimally invasive alternative to surgery for low back discogenic pain that merits further clinical evaluation.
Image-Guided Injection Using CT and 3D Navigation
Interventional treatment of the intervertebral disc requires:
- Precise diagnostic work-up and indication by experienced physicians
- Stem cell products that meet high quality standards
- Precision guidance of the stem cell implantation into the nucleus pulposus
- Sterile conditions to avoid infection
Patients considering any stem cell treatment should ask the clinic in detail about its diagnostic work-up, product quality, image guidance and hygiene standards. As with any injection into or near the spine, complications such as infection or nerve injury are possible, and careful technique and imaging help to reduce this risk.
Other Novel Treatment Options Aiming at Regenerating Rather Than Removing the Inter-Vertebral Disc
Several new treatments are emerging that are still in the beginning clinical trial phases:
- Glucosamine injections may offer pain relief for some patients and do not preclude the use of other treatment options.
- Inter-vertebral disc annuloplasty (IDET) is an interventional procedure with which the disc is heated to 90 °C for 15 minutes with the goal to seal the disc and inactivate nerves irritated by the degeneration.
- Invertebrate disc arthroplasty, also called Artificial Disc Replacement (ADR) or Total Disc Replacement (TDR), is a surgical procedure in which degenerated intervertebral discs are replaced with artificial ones, most frequently in the lumbar (lower) or cervical (upper) spine.
- Microdiscectomy is a minimally invasive surgical procedure in which a portion of a herniated nucleus pulposus is removed surgically by using small surgical instruments or laser under an operating microscope with minimal incisions and minimal disturbance of the structural elements of the spine.
- Percutaneous disc decompression is a minimally invasive, interventional procedure that reduces or eliminates a small portion of the bulging disc through a needle inserted into the disc, without requiring a surgical incision.
- Spinal decompression is a non-invasive procedure that temporarily (a few hours) enlarges the inter-vertebral foramen (IVF) by aiding in the rehydration of the spinal discs.
Do Bacteria Play a Role in Disc Degeneration?
It has been hypothesized that Cutibacterium acnes may play a role in disc degeneration. These bacteria have repeatedly been found in samples taken during discectomy, the surgical removal of inter-vertebral discs. Whether antibiotic treatment has a role in disc degeneration is still being studied. During interventional procedures on the disc, samples can be obtained for microbiological analysis; any decision on antibiotic treatment is made by the treating physician in line with the approved use of the medicinal product concerned.
Suffering From Back Pain? Contact us for More Information
If you are suffering from degenerative disc disease and back pain, contact us. Our physicians can explain the diagnostic work-up and discuss which treatment options may be suitable in your case, including established conservative, surgical and stem-cell-based approaches. Individual outcomes cannot be predicted, but our aim is to help you regain mobility and reduce pain.
ANOVA stem cell products are manufactured in our licensed laboratory in accordance with the applicable German and European legal and quality requirements.
ANOVA employs image-guided navigation, combining CT (computed tomography) imaging with an infra-red guidance system that displays the position of the instruments inside the body in a 3D view. This is used to support accurate needle placement and to help deliver the stem cells to the intended location while minimising the risk of injury to important anatomical structures.
Learn more about your options by contacting us directly. You can either make an appointment at our clinic or talk to us via Skype or WhatsApp. Call us today; our patient Care Managers will make all necessary arrangements for you.
News & Insights
Patient Services at ANOVA Institute for Regenerative Medicine
- Located in the center of Germany, quick access by car or train from anywhere in Europe
- Simple access worldwide, less than 20 minutes from Frankfurt Airport
- Individualized therapy with state-of-the-art autologous stem cell products
- Individually planned diagnostic work-up which include world-class MRI and CT scans
- German high quality standard on safety and quality assurance
- Personal service with friendly, dedicated Patient Care Managers
- Continuous analysis of scientific data in the field of regenerative medicine